Market Tracker

08/26 5:16pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

1.58
Delayed Data
As of Aug 26
 +0.02 / +1.28%
Today’s Change
1.01
Today|||52-Week Range
5.15
-34.71%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.56
Today’s open1.57
Day’s range1.56 - 1.64
Volume191,969
Average volume (3 months)791,178
Market cap$100.1M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+39.46%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...+0.02+0.26%
AKAOAchaogen Inc-0.06-1.59%
NVLSNivalis Therapeutics...+0.20+3.23%
MRTXMirati Therapeutics ...+0.11+2.21%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts